PSYCHOACTIVE cover image

Daniel Wolfe on Funding Global Harm Reduction

PSYCHOACTIVE

00:00

Global Use of Buprenorphine and Methadone for Harm Reduction

This chapter explores the regulations and policies surrounding the use of buprenorphine and methadone for harm reduction in opioid addiction worldwide. It emphasizes the need for a diverse range of treatment options and the importance of patient perspectives.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner
Get the app